ID24224A - Turunan-turunan 6-azaurasil sebagai inhibitor il-5 - Google Patents
Turunan-turunan 6-azaurasil sebagai inhibitor il-5Info
- Publication number
- ID24224A ID24224A IDW20000004A ID20000004A ID24224A ID 24224 A ID24224 A ID 24224A ID W20000004 A IDW20000004 A ID W20000004A ID 20000004 A ID20000004 A ID 20000004A ID 24224 A ID24224 A ID 24224A
- Authority
- ID
- Indonesia
- Prior art keywords
- azauracil
- declarations
- inhibitors
- azauracil declarations
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/0491—Sugars, nucleosides, nucleotides, oligonucleotides, nucleic acids, e.g. DNA, RNA, nucleic acid aptamers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D235/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings
- C07D235/02—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, condensed with other rings condensed with carbocyclic rings or ring systems
- C07D235/04—Benzimidazoles; Hydrogenated benzimidazoles
- C07D235/06—Benzimidazoles; Hydrogenated benzimidazoles with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/53—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
- A61K51/02—Preparations containing radioactive substances for use in therapy or testing in vivo characterised by the carrier, i.e. characterised by the agent or material covalently linked or complexing the radioactive nucleus
- A61K51/04—Organic compounds
- A61K51/041—Heterocyclic compounds
- A61K51/044—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
- A61K51/0461—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/14—Decongestants or antiallergics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D253/00—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00
- C07D253/02—Heterocyclic compounds containing six-membered rings having three nitrogen atoms as the only ring hetero atoms, not provided for by group C07D251/00 not condensed with other rings
- C07D253/06—1,2,4-Triazines
- C07D253/065—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members
- C07D253/07—1,2,4-Triazines having three double bonds between ring members or between ring members and non-ring members with hetero atoms, or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D253/075—Two hetero atoms, in positions 3 and 5
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a carbon chain containing aromatic rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Biotechnology (AREA)
- Biochemistry (AREA)
- Immunology (AREA)
- Ophthalmology & Optometry (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP97202117 | 1997-07-10 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ID24224A true ID24224A (id) | 2000-07-13 |
Family
ID=8228530
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IDW20000004A ID24224A (id) | 1997-07-10 | 1998-07-02 | Turunan-turunan 6-azaurasil sebagai inhibitor il-5 |
Country Status (20)
| Country | Link |
|---|---|
| US (2) | US6743792B2 (id) |
| EP (1) | EP1003729A1 (id) |
| JP (1) | JP2002508001A (id) |
| KR (1) | KR20010012614A (id) |
| CN (1) | CN1261881A (id) |
| AU (1) | AU756637B2 (id) |
| BR (1) | BR9811499A (id) |
| CA (1) | CA2294533A1 (id) |
| EE (1) | EE9900585A (id) |
| HR (1) | HRP990333A2 (id) |
| HU (1) | HUP0002826A3 (id) |
| ID (1) | ID24224A (id) |
| IL (1) | IL133915A0 (id) |
| NO (1) | NO20000094L (id) |
| NZ (1) | NZ501627A (id) |
| PL (1) | PL337875A1 (id) |
| SK (1) | SK180999A3 (id) |
| TR (1) | TR199903249T2 (id) |
| WO (1) | WO1999002504A1 (id) |
| ZA (1) | ZA986095B (id) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0987265A1 (en) | 1998-09-18 | 2000-03-22 | Janssen Pharmaceutica N.V. | Interleukin-5 inhibiting 6-azauracil derivatives |
| EP1133482B1 (en) * | 1998-11-23 | 2005-02-23 | Janssen Pharmaceutica N.V. | Il-5 inhibiting 6-azauracil derivatives |
| PL198205B1 (pl) * | 1998-12-18 | 2008-06-30 | Janssen Pharmaceutica Nv | Inhibitująca IL-5 pochodna 6-azauracylu, jej zastosowanie i sposób wytwarzania, kompozycja farmaceutyczna, sposób znaczenia in vitro receptora i sposób obrazowania in vitro narządu |
| ATE318811T1 (de) * | 1999-08-06 | 2006-03-15 | Janssen Pharmaceutica Nv | Interleukin-5 hemmende 6-azauracil derivate |
| US8073380B2 (en) * | 2005-12-30 | 2011-12-06 | Nokia Corporation | Media content delivery and recording over broadcast network |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3883527A (en) | 1973-10-19 | 1975-05-13 | Pfizer | Process for preparation of 2-aryl-1,3,4-triazine-3,5(2H,4H)-diones |
| US4631278A (en) * | 1984-08-01 | 1986-12-23 | Janssen Pharmaceutica N.V. | Anti-protozoal α-aryl-4-(4,5-dihydro-3,5-dioxo-1,2,4-triazin-2(3H)-yl)-benzeneacetonitrile derivatives, pharmaceutical compositions, and method of use therefor |
| GB8602342D0 (en) * | 1986-01-30 | 1986-03-05 | Janssen Pharmaceutica Nv | 5 6-dihydro-2-(substituted phenyl)-1 2 4-triazine-3 5(2h 4h)-diones |
| CA1331757C (en) * | 1988-02-29 | 1994-08-30 | Janssen Pharmaceutica Naamloze Vennootschap | 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols |
| EP0476439A1 (de) * | 1990-09-18 | 1992-03-25 | Bayer Ag | Substituierte 1,2,4-Triazindione, Verfahren zu ihrer Herstellung, Zwischenprodukte dafür und ihre Verwendung |
| DE4120138A1 (de) * | 1991-06-19 | 1992-12-24 | Bayer Ag | Substituierte hexahydro-1,2,4-triazindione, verfahren zu ihrer herstellung, zwischenprodukte dafuer und ihre verwendung |
| TW263495B (id) * | 1992-12-23 | 1995-11-21 | Celltech Ltd | |
| GB9304920D0 (en) * | 1993-03-10 | 1993-04-28 | Celltech Ltd | Chemical compounds |
| TW332201B (en) * | 1995-04-06 | 1998-05-21 | Janssen Pharmaceutica Nv | 1,3-Dihydro-1-(phenylalkyl)-2H-imidazol-2-one derivatives |
| DE69615601T2 (de) * | 1995-04-14 | 2002-07-11 | Takeda Schering Plough Animal | Verfahren zur Herstellung von Triazinderivate |
-
1998
- 1998-07-02 CN CN98806918A patent/CN1261881A/zh active Pending
- 1998-07-02 JP JP50812799A patent/JP2002508001A/ja not_active Withdrawn
- 1998-07-02 CA CA002294533A patent/CA2294533A1/en not_active Abandoned
- 1998-07-02 WO PCT/EP1998/004192 patent/WO1999002504A1/en not_active Application Discontinuation
- 1998-07-02 TR TR1999/03249T patent/TR199903249T2/xx unknown
- 1998-07-02 SK SK1809-99A patent/SK180999A3/sk unknown
- 1998-07-02 PL PL98337875A patent/PL337875A1/xx unknown
- 1998-07-02 ID IDW20000004A patent/ID24224A/id unknown
- 1998-07-02 EP EP98935022A patent/EP1003729A1/en not_active Withdrawn
- 1998-07-02 KR KR1019997010573A patent/KR20010012614A/ko not_active Application Discontinuation
- 1998-07-02 IL IL13391598A patent/IL133915A0/xx unknown
- 1998-07-02 NZ NZ501627A patent/NZ501627A/en unknown
- 1998-07-02 EE EEP199900585A patent/EE9900585A/xx unknown
- 1998-07-02 BR BR9811499-9A patent/BR9811499A/pt not_active IP Right Cessation
- 1998-07-02 HU HU0002826A patent/HUP0002826A3/hu unknown
- 1998-07-02 AU AU84413/98A patent/AU756637B2/en not_active Ceased
- 1998-07-09 ZA ZA9806095A patent/ZA986095B/xx unknown
-
1999
- 1999-10-29 HR HR97202117.4A patent/HRP990333A2/hr not_active Application Discontinuation
-
2000
- 2000-01-07 NO NO20000094A patent/NO20000094L/no unknown
-
2001
- 2001-05-14 US US09/855,068 patent/US6743792B2/en not_active Expired - Fee Related
-
2003
- 2003-05-09 US US10/434,896 patent/US6951857B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| AU756637B2 (en) | 2003-01-16 |
| EP1003729A1 (en) | 2000-05-31 |
| EE9900585A (et) | 2000-08-15 |
| KR20010012614A (ko) | 2001-02-15 |
| TR199903249T2 (xx) | 2000-09-21 |
| HRP990333A2 (en) | 2000-04-30 |
| US6743792B2 (en) | 2004-06-01 |
| NZ501627A (en) | 2002-02-01 |
| US20020042416A1 (en) | 2002-04-11 |
| HUP0002826A2 (hu) | 2001-04-28 |
| AU8441398A (en) | 1999-02-08 |
| BR9811499A (pt) | 2000-09-19 |
| CA2294533A1 (en) | 1999-01-21 |
| PL337875A1 (en) | 2000-09-11 |
| JP2002508001A (ja) | 2002-03-12 |
| NO20000094D0 (no) | 2000-01-07 |
| ZA986095B (en) | 2000-01-10 |
| NO20000094L (no) | 2000-03-08 |
| US6951857B2 (en) | 2005-10-04 |
| IL133915A0 (en) | 2001-04-30 |
| SK180999A3 (en) | 2000-10-09 |
| US20030220331A1 (en) | 2003-11-27 |
| WO1999002504A1 (en) | 1999-01-21 |
| CN1261881A (zh) | 2000-08-02 |
| HUP0002826A3 (en) | 2003-01-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1224195E (pt) | C-aril-glicosidos inibidores de tgls2 | |
| ATE245142T1 (de) | No-synthase inhibitoren | |
| DK2253620T3 (da) | Substituerede 3-cyanoquinoliner som protein-tyrosinkinase-inhibitorer | |
| DK2028186T3 (da) | Hepatitis C inhibitor tri-peptider | |
| ID19198A (id) | Inhibitor metaloprotease heterosiklik | |
| PT1049695E (pt) | Imidazotriazinonas 2-fenil substituidas enquanto inibidores de fosfodiesterase | |
| ID18416A (id) | Inhibitor metaloprotease diheterosiklik | |
| DK0958287T3 (da) | Sulfamidmetalloprotease-inhibitorer | |
| PT1181017E (pt) | Inibidores de metaloproteases | |
| DK1027332T3 (da) | Hidtil ukendte lactametalloproteaseinhibitorer | |
| ID27574A (id) | Inhibitor enzim | |
| PT1194404E (pt) | Inibidores de aspartil-protease | |
| PT1047450E (pt) | Combinacoes inibidor ace - inibidor mmp | |
| DE69837922D1 (de) | Il-5 hemmende 6-azauracilderivate | |
| ATE252547T1 (de) | Matrixmetalloproteinaseinhibitoren | |
| PT1137632E (pt) | Tioureias inibidoras de virus herpes | |
| MA24877A1 (fr) | INHIBITEURS DE PROTéASES | |
| DE69903779D1 (de) | Inhibitor- Schalter | |
| DE60009260D1 (de) | Thiopyranderivate as mmp-inhibitoren | |
| ID24224A (id) | Turunan-turunan 6-azaurasil sebagai inhibitor il-5 | |
| ID23196A (id) | Gandaran untuk lampuflouresen | |
| DE69828361D1 (de) | Apoptose-inhibitor | |
| DE69907254D1 (de) | 6-azauracilderivate als il-5 inhibitoren | |
| NO993161D0 (no) | Cyklooksygenaseinhibitor | |
| DK1140873T3 (da) | IL-5-inhiberende 6-azauracilderivater |